DNA-reactive B cells in lupus

Current Opinion in Immunology

Volumn 43, Issue , 2016, Pages 1-7

  Suurmond, Jolien ^a   Calise, Justine ^a,b   Malkiel, Susan ^a   Diamond, Betty ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA ANTIBODY; IMMUNOGLOBULIN G; ANTINUCLEAR ANTIBODY;

AUTOIMMUNITY; B LYMPHOCYTE; DISEASE ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENETIC RISK; HUMAN; LUPUS VULGARIS; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ALLELE; ANIMAL; B LYMPHOCYTE SUBPOPULATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; RISK;

ALLELES; ANIMALS; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; DNA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK;

EID: 84982845422     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.07.002     Document Type: Review

References (62)

1. 1 Gaynor, B., Putterman, C., Valadon, P., Spatz, L., Scharff, M.D., Diamond, B., Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A 94 (1997), 1955–1960.
2. 2 Raz, E., Brezis, M., Rosenmann, E., Eilat, D., Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 142 (1989), 3076–3082.
3. 3 Clynes, R., Dumitru, C., Ravetch, J.V., Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 (1998), 1052–1054.
4. 4 Lovgren, T., Eloranta, M.L., Bave, U., Alm, G.V., Ronnblom, L., Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50 (2004), 1861–1872.
5. 5 Means, T.K., Latz, E., Hayashi, F., Murali, M.R., Golenbock, D.T., Luster, A.D., Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115 (2005), 407–417.
6. 6 Fields, M.L., Erikson, J., The regulation of lupus-associated autoantibodies: immunoglobulin transgenic models. Curr Opin Immunol 15 (2003), 709–717.
7. 7 Kumar, K.R., Mohan, C., Understanding B-cell tolerance through the use of immunoglobulin transgenic models. Immunol Res 40 (2008), 208–223.
8. 8 Kiefer, K., Nakajima, P.B., Oshinsky, J., Seeholzer, S.H., Radic, M., Bosma, G.C., Bosma, M.J., Antigen receptor editing in anti-DNA transitional B cells deficient for surface IgM. J Immunol 180 (2008), 6094–6106.
9. 9 Cohen-Solal, J., Diamond, B., Lessons from an anti-DNA autoantibody. Mol Immunol 48 (2011), 1328–1331.
10. 10 Cambier, J.C., Gauld, S.B., Merrell, K.T., Vilen, B.J., B-cell anergy: from transgenic models to naturally occurring anergic B cells?. Nat Rev Immunol 7 (2007), 633–643.
11. 11 Vas, J., Gronwall, C., Marshak-Rothstein, A., Silverman, G.J., Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes. Arthritis Rheum 64 (2012), 3388–3398.
12. 12 Cerutti, A., Cols, M., Puga, I., Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13 (2013), 118–132.
13. 13 Roy, B., Shukla, S., Lyszkiewicz, M., Krey, M., Viegas, N., Duber, S., Weiss, S., Somatic hypermutation in peritoneal B1b cells. Mol Immunol 46 (2009), 1613–1619.
14. 14 Hande, S., Notidis, E., Manser, T., Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development. Immunity 8 (1998), 189–198.
15. 15 Notidis, E., Heltemes, L., Manser, T., Dominant, hierarchical induction of peripheral tolerance during foreign antigen-driven B cell development. Immunity 17 (2002), 317–327.
16. 16 Alabyev, B., Rahman, Z.S., Manser, T., Quantitatively reduced participation of anti-nuclear antigen B cells that down-regulate B cell receptor during primary development in the germinal center/memory B cell response to foreign antigen. J Immunol 178 (2007), 5623–5634.
17. 17 Rice, J.S., Newman, J., Wang, C., Michael, D.J., Diamond, B., Receptor editing in peripheral B cell tolerance. Proc Natl Acad Sci U S A 102 (2005), 1608–1613.
18. 18 Wang, Y.H., Diamond, B., B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice. J Clin Invest 118 (2008), 2896–2907.
19. 19•• Vogelpoel, L.T., Hansen, I.S., Rispens, T., Muller, F.J., van Capel, T.M., Turina, M.C., Vos, J.B., Baeten, D.L., Kapsenberg, M.L., de Jong, E.C., et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun, 5, 2014, 5444 This study shows that the presence of autoantibody-TLR ligand immune complexes leads to skewing of M2 macrophages towards a proinflammatory phenotype and can thus contribute to an inflammatory feedforward loop we describe in this manuscript.
20. FH can produce BAFF (BLyS), and by using T cell-specific BAFF deletion in BM chimeras, they show that locally produced and T cell-derived BAFF can regulate selection of B cells in the germinal center.
21. 21 Ota, M., Duong, B.H., Torkamani, A., Doyle, C.M., Gavin, A.L., Ota, T., Nemazee, D., Regulation of the B cell receptor repertoire and self-reactivity by BAFF. J Immunol 185 (2010), 4128–4136.
22. 22 Moisini, I., Huang, W., Bethunaickan, R., Sahu, R., Ricketts, P.G., Akerman, M., Marion, T., Lesser, M., Davidson, A., The Yaa locus and IFN-alpha fine-tune germinal center B cell selection in murine systemic lupus erythematosus. J Immunol 189 (2012), 4305–4312.
23. 23 Wardemann, H., Yurasov, S., Schaefer, A., Young, J.W., Meffre, E., Nussenzweig, M.C., Predominant autoantibody production by early human B cell precursors. Science 301 (2003), 1374–1377.
24. 24 Tsuiji, M., Yurasov, S., Velinzon, K., Thomas, S., Nussenzweig, M.C., Wardemann, H., A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 203 (2006), 393–400.
25. 25 Tiller, T., Tsuiji, M., Yurasov, S., Velinzon, K., Nussenzweig, M.C., Wardemann, H., Autoreactivity in human IgG+ memory B cells. Immunity 26 (2007), 205–213.
26. 26 Scheid, J.F., Mouquet, H., Kofer, J., Yurasov, S., Nussenzweig, M.C., Wardemann, H., Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells. Proc Natl Acad Sci U S A 108 (2011), 18044–18048.
27. 27•• Malkiel, S., Jeganathan, V., Wolfson, S., Orduno, N.M., Marasco, E., Aranow, C., Mackay, M., Gregersen, P.K., Diamond, B., Checkpoints for autoreactive B cells in peripheral blood of lupus patients assessed by flow cytometry. Arthritis Rheumatol, 2016, 10.1002/art.39710 The authors developed a flow cytometry assay to easily identify autoreactive B cells recognizing nuclear antigens (ANA+ B cells). Both lupus patients and healthy individuals displayed transitional/naïve and naïve/memory B cell tolerance checkpoints of ANA+ B cells; however, anergy induction was impaired in lupus patients.
28. 28 Koelsch, K., Zheng, N.Y., Zhang, Q., Duty, A., Helms, C., Mathias, M.D., Jared, M., Smith, K., Capra, J.D., Wilson, P.C., Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest 117 (2007), 1558–1565.
29. 29 Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V., Nussenzweig, M.C., Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 201 (2005), 703–711.
30. 30 Isnardi, I., Ng, Y.S., Srdanovic, I., Motaghedi, R., Rudchenko, S., von Bernuth, H., Zhang, S.Y., Puel, A., Jouanguy, E., Picard, C., et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29 (2008), 746–757.
31. 31 Mietzner, B., Tsuiji, M., Scheid, J., Velinzon, K., Tiller, T., Abraham, K., Gonzalez, J.B., Pascual, V., Stichweh, D., Wardemann, H., et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A 105 (2008), 9727–9732.
32. 32 Jacobi, A.M., Zhang, J., Mackay, M., Aranow, C., Diamond, B., Phenotypic characterization of autoreactive B cells — checkpoints of B cell tolerance in patients with systemic lupus erythematosus. PLoS One, 4, 2009, e5776.
33. 33 Cappione, A. 3rd, Anolik, J.H., Pugh-Bernard, A., Barnard, J., Dutcher, P., Silverman, G., Sanz, I., Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 115 (2005), 3205–3216.
34. 34 Arbuckle, M.R., McClain, M.T., Rubertone, M.V., Scofield, R.H., Dennis, G.J., James, J.A., Harley, J.B., Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349 (2003), 1526–1533.
35. 35• Tipton, C.M., Fucile, C.F., Darce, J., Chida, A., Ichikawa, T., Gregoretti, I., Schieferl, S., Hom, J., Jenks, S., Feldman, R.J., et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol 16 (2015), 755–765 Through the use of deep sequencing of immunoglobulin heavy chain variable region genes, this group discovered that a considerable portion of plasmablasts during SLE flares derive from a subset they define as activated naïve B cells. Understanding the different types of B cells involved in maintaining an autoreactive response is crucial in the development of effective targeted therapeutics.
36. 36 Deng, Y., Tsao, B.P., Advances in lupus genetics and epigenetics. Curr Opin Rheumatol 26 (2014), 482–492.
37. 37 Liu, L., Yin, X., Wen, L., Yang, C., Sheng, Y., Lin, Y., Zhu, Z., Shen, C., Shi, Y., Zheng, Y., et al. Several critical cell types, tissues, and pathways are implicated in genome-wide association studies for systemic lupus erythematosus. G3 (Bethesda) 6 (2016), 1503–1511.
38. 38• Gutierrez-Arcelus, M., Rich, S.S., Raychaudhuri, S., Autoimmune diseases - connecting risk alleles with molecular traits of the immune system. Nat Rev Genet 17 (2016), 160–174 This article discusses methods to study human gene expression data sets and their utilization to infer immune cell subsets that are affected by genetic risk alleles. This methodology represents a novel approach to understand human autoimmunity.
39. 39 Mok, C.C., Update on B-cell targeted therapies for systemic lupus erythematosus. Exp Opin Biol Ther 14 (2014), 773–788.
40. 40 Nakayamada, S., Iwata, S., Tanaka, Y., Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus. Int J Rheum Dis 18 (2015), 208–218.
41. 41 Chung, S.A., Taylor, K.E., Graham, R.R., Nititham, J., Lee, A.T., Ortmann, W.A., Jacob, C.O., Alarcon-Riquelme, M.E., Tsao, B.P., Harley, J.B., et al. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet, 7, 2011, e1001323.
42. 42 Kozyrev, S.V., Abelson, A.K., Wojcik, J., Zaghlool, A., Linga Reddy, M.V., Sanchez, E., Gunnarsson, I., Svenungsson, E., Sturfelt, G., Jonsen, A., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 40 (2008), 211–216.
43. 43 Yokoyama, K., Su Ih, I.H., Tezuka, T., Yasuda, T., Mikoshiba, K., Tarakhovsky, A., Yamamoto, T., BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor. EMBO J 21 (2002), 83–92.
44. 44 Tretter, T., Ross, A.E., Dordai, D.I., Desiderio, S., Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk. J Exp Med 198 (2003), 1863–1873.
45. 45 Bewarder, N., Weinrich, V., Budde, P., Hartmann, D., Flaswinkel, H., Reth, M., Frey, J., In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation. Mol Cell Biol 16 (1996), 4735–4743.
46. 46 Simpfendorfer, K.R., Olsson, L.M., Manjarrez Orduno, N., Khalili, H., Simeone, A.M., Katz, M.S., Lee, A.T., Diamond, B., Gregersen, P.K., The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development. Hum Mol Genet 21 (2012), 3918–3925.
47. 47 Simpfendorfer, K.R., Armstead, B.E., Shih, A., Li, W., Curran, M., Manjarrez-Orduno, N., Lee, A.T., Diamond, B., Gregersen, P.K., Autoimmune disease-associated haplotypes of BLK exhibit lowered thresholds for B cell activation and expansion of Ig class-switched B cells. Arthritis Rheumatol 67 (2015), 2866–2876.
48. 48 Manjarrez-Orduno, N., Marasco, E., Chung, S.A., Katz, M.S., Kiridly, J.F., Simpfendorfer, K.R., Freudenberg, J., Ballard, D.H., Nashi, E., Hopkins, T.J., et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet 44 (2012), 1227–1230.
49. 49 Floto, R.A., Clatworthy, M.R., Heilbronn, K.R., Rosner, D.R., MacAry, P.A., Rankin, A., Lehner, P.J., Ouwehand, W.H., Allen, J.M., Watkins, N.A., et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 11 (2005), 1056–1058.
50. 50 Blank, M.C., Stefanescu, R.N., Masuda, E., Marti, F., King, P.D., Redecha, P.B., Wurzburger, R.J., Peterson, M.G., Tanaka, S., Pricop, L., Decreased transcription of the human FCGR2B gene mediated by the — 343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 117 (2005), 220–227.
51. 51 Kono, H., Kyogoku, C., Suzuki, T., Tsuchiya, N., Honda, H., Yamamoto, K., Tokunaga, K., Honda, Z., FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 14 (2005), 2881–2892.
52. 52 Lazzari, E., Jefferies, C.A., IRF5-mediated signaling and implications for SLE. Clin Immunol 153 (2014), 343–352.
53. 53 Lien, C., Fang, C.M., Huso, D., Livak, F., Lu, R., Pitha, P.M., Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A 107 (2010), 4664–4668.
54. 54 Sigurdsson, S., Nordmark, G., Garnier, S., Grundberg, E., Kwan, T., Nilsson, O., Eloranta, M.L., Gunnarsson, I., Svenungsson, E., Sturfelt, G., et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet 17 (2008), 2868–2876.
55. 55 Niewold, T.B., Kelly, J.A., Flesch, M.H., Espinoza, L.R., Harley, J.B., Crow, M.K., Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 58 (2008), 2481–2487.
56. 56 Feng, D., Stone, R.C., Eloranta, M.L., Sangster-Guity, N., Nordmark, G., Sigurdsson, S., Wang, C., Alm, G., Syvanen, A.C., Ronnblom, L., et al. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum 62 (2010), 562–573.
57. 57 Stone, R.C., Feng, D., Deng, J., Singh, S., Yang, L., Fitzgerald-Bocarsly, P., Eloranta, M.L., Ronnblom, L., Barnes, B.J., Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis Rheum 64 (2012), 788–798.
58. 58 Kim, S.J., Zou, Y.R., Goldstein, J., Reizis, B., Diamond, B., Tolerogenic function of Blimp-1 in dendritic cells. J Exp Med 208 (2011), 2193–2199.
59. 59 Kim, S.J., Gregersen, P.K., Diamond, B., Regulation of dendritic cell activation by microRNA let-7c and BLIMP1. J Clin Invest 123 (2013), 823–833.
60. 60 Smyth, D., Cooper, J.D., Collins, J.E., Heward, J.M., Franklyn, J.A., Howson, J.M., Vella, A., Nutland, S., Rance, H.E., Maier, L., et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 (2004), 3020–3023.
61. 61 Rieck, M., Arechiga, A., Onengut-Gumuscu, S., Greenbaum, C., Concannon, P., Buckner, J.H., Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 179 (2007), 4704–4710.
62. 62 Arechiga, A.F., Habib, T., He, Y., Zhang, X., Zhang, Z.Y., Funk, A., Buckner, J.H., Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 182 (2009), 3343–3347.